Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IART | IRMD |
|---|---|---|
| Price | $13.00 | $85.47 |
| Change today | ▼ 2.40% | ▲ 0.77% |
| Market cap | $1.01B | $1.09B |
| Return, 3 months | -29.3% | -12.6% |
| Return, year to date | +4.7% | -11.6% |
| Return, 1 year | -12.2% | +12.7% |
| P/E (TTM) | -144.4 | 47.7 |
| P/B | 1.0 | 10.7 |
| P/E percentile vs own 5y | 14th | 72nd |
| Dividend yield | – | 0.87% |
| Revenue growth (YoY, latest qtr) | +0.8% | +0.3% |
| Net profit growth (YoY) | +100.9% | -9.6% |
| Gross margin | 52.5% | 75.9% |
| Operating margin | 4.0% | 31.9% |
| Net margin | -0.4% | 26.7% |
| Return on equity | -0.7% | 23.5% |
| Analyst target vs. price | +30.8% | +40.4% |
| Analyst buy share | 0% | 50% |
| RSI (14) | 31 | 49 |
| 30-day volatility | 78.1% | 22.0% |
| Max drawdown, 1 year | -44.8% | -21.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
